According to the Patsnap Bio Sequence Database, the top 10 applicants for the toripalimab patent are as follows: Shanghai Junshi Biosciences with 52 applications, Cugene with 30 applications, and Guangzhou Zhiyi Biotech with 16 applications. For more applicants, please refer to the image below.
In molecular biology and bioinformatics, a consensus sequence is a sequence of DNA, RNA, or protein that represents the most common or typical sequence found in a specific location within a population.
Exploring the changes occurring within the application structure amongst Tirzepatide's top 10 patent assignees over time delivers insights into the competitive landscape's evolution.
Exploring the changes occurring within the application structure amongst Trontinemab's top 10 patent assignees over time delivers insights into the competitive landscape's evolution.
Attenuator in biotechnology refers to a nucleotide sequence in DNA that can lead to premature termination of transcription, a process found in bacteria and archaea.
In mapping the evolutionary trajectory of the patenting landscape pertaining to Mirvetuximab Soravtansine, it is critical to analyze the strategic approach of the top 10 assignees. There is also a dynamic shift in the competition blueprint that is dictated by the progression of time.